InvestSMART

ORDINARY FULLY PAID (ASX: OPT) - Announcements

DELISTED - Current share price for OPT : $0.013

ASX company news and announcements for ORDINARY FULLY PAID (OPT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ORDINARY FULLY PAID (OPT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ORDINARY FULLY PAID (OPT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ORDINARY FULLY PAID (OPT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 Appendix 3B 2 Dec 2019 8:34AM $2.730 $0.013 fallen by 99.52%
$18 Opthea Equity Raising Presentation 2 Dec 2019 8:29AM $2.730 $0.013 fallen by 99.52%
$18 Opthea Raises A$50 million in Institutional Placement 2 Dec 2019 8:27AM $2.730 $0.013 fallen by 99.52%
$18 Ceasing to be a substantial holder 28 Nov 2019 2:28PM $2.920 $0.013 fallen by 99.55%
$18 Becoming a substantial holder 26 Nov 2019 5:10PM $2.710 $0.013 fallen by 99.52%
$18 Ceasing to be a substantial holder 25 Nov 2019 6:07PM $2.850 $0.013 fallen by 99.54%
$18 Results of Meeting 21 Nov 2019 4:01PM $2.770 $0.013 fallen by 99.53%
$18 Opthea CEO Presentation to the 2019 AGM 21 Nov 2019 9:51AM $3.000 $0.013 fallen by 99.57%
$18 Opthea Chairman Address to the 2019 AGM 21 Nov 2019 9:51AM $3.000 $0.013 fallen by 99.57%
$18 Change in substantial holding 20 Nov 2019 6:12PM n/a $0.013 n/a
$18 Ceasing to be a substantial holder 29 Oct 2019 4:44PM $3.440 $0.013 fallen by 99.62%
$18 Opthea Clinical Data Published in Leading Ophthalmic Journal 29 Oct 2019 8:41AM $3.480 $0.013 fallen by 99.63%
$18 Becoming a substantial holder 24 Oct 2019 2:36PM $3.710 $0.013 fallen by 99.65%
$18 Notice of Annual General Meeting and Proxy Form 18 Oct 2019 5:00PM $3.580 $0.013 fallen by 99.64%
$18 Appendix 4G and Corporate Governance Statement 2019 18 Oct 2019 4:57PM $3.580 $0.013 fallen by 99.64%
$18 Annual Report 2019 18 Oct 2019 4:54PM $3.580 $0.013 fallen by 99.64%
$18 Opthea Presentation for Ophthalmology Innovation Summit 11 Oct 2019 9:08AM $3.450 $0.013 fallen by 99.62%
$18 Opthea Presents Additional Data from Ph2b Trial at OIS in US 11 Oct 2019 9:03AM $3.450 $0.013 fallen by 99.62%
$18 Change in substantial holding 9 Oct 2019 1:53PM $3.420 $0.013 fallen by 99.62%
$18 Becoming a substantial holder 8 Oct 2019 6:30PM $3.410 $0.013 fallen by 99.62%
$18 Ceasing to be a substantial holder 8 Oct 2019 10:38AM $3.350 $0.013 fallen by 99.61%
$18 Opthea to Present at Ophthalmology Innovation Summit in US 3 Oct 2019 8:26AM $3.500 $0.013 fallen by 99.63%
$18 Opthea Receives A$14.6m R&D Tax Incentive 1 Oct 2019 8:47AM $3.350 $0.013 fallen by 99.61%
$18 Appendix 3B 30 Sep 2019 8:57AM $3.430 $0.013 fallen by 99.62%
$18 Change in substantial holding 13 Sep 2019 8:18AM $3.310 $0.013 fallen by 99.61%

551 - 575 of 733 results

Page 23 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.